Aprogen Medicines Inc. (KRX:007460)

Market Cap	219.07B
Revenue (ttm)	126.09B
Net Income (ttm)	-50.93B
Shares Out	308.55M
EPS (ttm)	-175.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,965,178
Average Volume	6,537,533
Open	709.00
Previous Close	709.00
Day's Range	691.00 - 712.00
52-Week Range	556.00 - 952.00
Beta	0.03
RSI	54.69
Earnings Date	Nov 13, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 256
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.